loadpatents
Patent applications and USPTO patent grants for Roschke; Viktor.The latest application filed is for "trail compositions with reduced immunogenicity".
Patent | Date |
---|---|
Trail Compositions With Reduced Immunogenicity App 20210380653 - Sokoloff; Alex ;   et al. | 2021-12-09 |
Multivalent and monovalent multispecific complexes and their uses Grant 10,526,381 - Roschke , et al. J | 2020-01-07 |
EGFR-binding modular recognition domains Grant 10,150,800 - Roschke , et al. Dec | 2018-12-11 |
Polynucleotides encoding angiopoietin-2 (ang-2) binding polypeptides Grant 10,087,222 - Roschke , et al. October 2, 2 | 2018-10-02 |
Ang-2 Binding Modular Recognition Domain Complexes and Pharmaceutical Compositions Thereof App 20180072783 - ROSCHKE; Viktor ;   et al. | 2018-03-15 |
Multivalent and Monovalent Multispecific Complexes and Their Uses App 20170298106 - ROSCHKE; Viktor ;   et al. | 2017-10-19 |
Ang-2-binding modular recognition domain complexes and pharmaceutical compositions thereof Grant 9,676,833 - Roschke , et al. June 13, 2 | 2017-06-13 |
Humanized antibodies against TL1A Grant 9,416,185 - Smith , et al. August 16, 2 | 2016-08-16 |
Ang-2 Binding Complexes and Uses Thereof App 20160176934 - ROSCHKE; Viktor ;   et al. | 2016-06-23 |
Multivalent And Monovalent Multispecific Complexes And Their Uses App 20160046678 - ROSCHKE; Viktor ;   et al. | 2016-02-18 |
Multivalent and Monovalent Multispecific Complexes and Their Uses App 20150210765 - ROSCHKE; VIKTOR ;   et al. | 2015-07-30 |
Humanized Antibodies Against Tl1a App 20140315250 - SMITH; Rodger ;   et al. | 2014-10-23 |
Humanized antibodies against TL1A Grant 8,728,482 - Smith , et al. May 20, 2 | 2014-05-20 |
BChE ALBUMIN FUSIONS FOR THE TREATMENT OF COCAINE ABUSE App 20140065126 - Sklair-Tavron; Liora ;   et al. | 2014-03-06 |
Multivalent and Monovalent Multispecific Complexes and Their Uses App 20140065142 - ROSCHKE; Viktor ;   et al. | 2014-03-06 |
Humanized Antibodies Against Light And Uses Thereof App 20130323240 - Smith; Rodger ;   et al. | 2013-12-05 |
Humanized Antibodies Against Cxcr3 App 20130274447 - Smith; Rodger ;   et al. | 2013-10-17 |
Ang-2 Binding Complexes and Uses Thereof App 20130259868 - ROSCHKE; Viktor ;   et al. | 2013-10-03 |
BChE albumin fusions for the treatment of cocaine abuse Grant 8,541,373 - Sklair-Tavron , et al. September 24, 2 | 2013-09-24 |
Humanized antibodies against LIGHT and uses thereof Grant 8,524,869 - Smith , et al. September 3, 2 | 2013-09-03 |
Humanized antibodies against CXCR3 Grant 8,435,522 - Smith , et al. May 7, 2 | 2013-05-07 |
Humanized Antibodies Against Tl1a App 20120308480 - Smith; Rodger ;   et al. | 2012-12-06 |
Humanized antibodies against TL1A Grant 8,263,743 - Smith , et al. September 11, 2 | 2012-09-11 |
Humanized Antibodies Against Light And Uses Thereof App 20120100074 - Smith; Rodger ;   et al. | 2012-04-26 |
Ang-2 Binding Complexes and Uses Thereof App 20120100166 - Roschke; Viktor ;   et al. | 2012-04-26 |
BChE ALBUMIN FUSIONS FOR THE TREATMENT OF COCAINE ABUSE App 20110312900 - Sklair-Tavron; Liora ;   et al. | 2011-12-22 |
Human G-Protein Chemokine Receptor (CCR5) HDGNR10 App 20110081360 - Roschke; Viktor ;   et al. | 2011-04-07 |
Method of inhibiting human G-protein chemokine receptor (CCR5) HDGNR10 Grant 7,862,818 - Roschke , et al. January 4, 2 | 2011-01-04 |
Humanized Antibodies Against App 20100047238 - Smith; Rodger ;   et al. | 2010-02-25 |
Vascular Endothelial Growth Factor-2 App 20090317394 - ALDERSON; RALPH ;   et al. | 2009-12-24 |
Humanized Antibodies Against Tl1a App 20090280116 - SMITH; Rodger ;   et al. | 2009-11-12 |
Human G-Protein Chemokine Receptor (CCR5) HDGNR10 App 20090226416 - Roschke; Viktor ;   et al. | 2009-09-10 |
Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies Grant 7,524,501 - Alderson , et al. April 28, 2 | 2009-04-28 |
Human G-protein chemokine receptor (CCR5) HDGNR10 Grant 7,501,123 - Roschke , et al. March 10, 2 | 2009-03-10 |
Antibodies Against Human G-Protein Chemokine Receptor (CCR5) HDGNR10 App 20090047735 - ROSCHKE; Viktor ;   et al. | 2009-02-19 |
Human G-protein chemokine receptor (CCR5) HDGNR10 Grant 7,393,934 - Roschke , et al. July 1, 2 | 2008-07-01 |
Antibodies That Immunospecifically Bind to TRAIL Receptors App 20070292411 - Salcedo; Theodora W. ;   et al. | 2007-12-20 |
Human G-protein chemokine receptor (CCR5) HDGNR10 App 20070122405 - Roschke; Viktor ;   et al. | 2007-05-31 |
Use of vascular endothelial growth factor to treat photoreceptor cells Grant 7,223,724 - Alderson , et al. May 29, 2 | 2007-05-29 |
Human G-protein Chemokine Receptor (CCR5) HDGNR10 Grant 7,175,988 - Roschke , et al. February 13, 2 | 2007-02-13 |
Antibodies that specifically bind to GMAD Grant 7,109,302 - Baker , et al. September 19, 2 | 2006-09-19 |
Antibodies that immunospecifically bind to TRAIL receptors App 20060062786 - Salcedo; Theodora W. ;   et al. | 2006-03-23 |
29 human cancer associated proteins App 20050208565 - Roschke, Viktor | 2005-09-22 |
Vascular endothelial growth factor-2 App 20050181979 - Alderson, Ralph ;   et al. | 2005-08-18 |
Human G-protein chemokine receptor (CCR5) HDGNR10 App 20050154193 - Roschke, Viktor ;   et al. | 2005-07-14 |
Antibodies that immunospecifically bind to TRAIL receptors App 20030228309 - Salcedo, Theodora ;   et al. | 2003-12-11 |
Human G-protein chemokine receptor (CCR5) HDGNR10 App 20030166024 - Rosen, Craig A. ;   et al. | 2003-09-04 |
Human G-protein Chemokine Receptor (CCR5) HDGNR10 App 20030100058 - Roschke, Viktor ;   et al. | 2003-05-29 |
TM4SF polynucleotides, polypeptides, and antibodies App 20030050466 - Ni, Jian ;   et al. | 2003-03-13 |
29 human cancer associated proteins App 20030027776 - Roschke, Viktor | 2003-02-06 |
Human G-protein Chemokine receptor (CCR5) HDGNR10 App 20020061834 - Rosen, Craig A. ;   et al. | 2002-05-23 |
Human G-protein Chemokine Receptor HDGNR10 App 20020048786 - Rosen, Craig A. ;   et al. | 2002-04-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.